Defence To Connect With Industry Leaders And Potential Partners During The Jp Morgan Healthcare Conference In San Francisco. Plans To Expand The Next Generation Of Radio-Immuno Conjugates In 2025

Defence To Connect With Industry Leaders And Potential Partners During The Jp Morgan Healthcare Conference In San Francisco. Plans To Expand The Next Generation Of Radio-Immuno Conjugates In 2025

Montreal, QC, Canada, January 10, 2025 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC) a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug...
Defence Fortifies Patent Portfolio

Defence Fortifies Patent Portfolio

Vancouver, BC, Canada, January 6, 2025 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC) a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug...